Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Taro Pharmaceutical Industries Ltd (NYSE:TARO)

141.53
Delayed Data
As of 9:35am ET
 +0.93 / +0.66%
Today’s Change
130.45
Today|||52-Week Range
173.00
-4.49%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues130.2M250.8M237.7M244.2M
 
 
 
 
 
Cost of Goods Sold40.9M48.7M40.3M40.7M
 
 
 
 
 
Depreciation And Amortization4.0M4.0M3.9M3.9M
 
 
 
 
 
 
Operating ExpensesGross Income85.4M198.1M193.5M199.6M
 
 
 
 
 
General Expenses37.4M35.5M34.2M46.1M
 
 
 
 
 
Research And Development15.0M13.8M12.8M23.9M
 
 
 
 
 
Total Operating Expenses82.2M88.3M78.4M90.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income48.0M162.6M159.3M153.5M
 
 
 
 
 
Extraordinary Credit6.5M------
 
 
Extraordinary Charge---2.3M----
 
 
Other Expenses-4.8M7.7M8.6M32.9M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income51.2M170.0M170.9M189.5M
 
 
 
 
 
Income Taxes-4.9M-26.1M-28.2M-36.9M
 
 
 
 
 
Minority Interest-100.0K-319.0K-132.0K-26.0K
 
 
 
 
 
Discontinued Operations-124.0K-223.0K-126.0K-314.0K
 
 
 
 
 
Net Income46.1M143.4M142.5M152.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS42.8M42.8M42.8M42.8M
 
 
 
 
 
Shares To Calculate EPS Diluted42.8M42.8M42.8M42.8M
 
 
 
 
 
 
Earnings Per ShareEPS$1.08$3.35$3.33$3.56
 
 
 
 
 
EPS Diluted$1.08$3.35$3.33$3.56